65 related articles for article (PubMed ID: 27669503)
1. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes after amputation and sentinel node biopsy for subungual melanoma: A single-institution series.
Valenzuela CD; Fowler G; Kozuma K; Kusaka S; Vetto JT
Am J Surg; 2024 May; 231():79-85. PubMed ID: 38492992
[TBL] [Abstract][Full Text] [Related]
3. Polo-Like Kinase 4 Correlates with Aggressive Tumor Characteristics, Shortened Disease-Free Survival and Overall Survival in Patients with Cutaneous Melanoma who Undergo Surgical Resection.
Zhang L; Zhang S; Han Z; Liu Z; Xu Y; Li X; Miao G; Niu L
Tohoku J Exp Med; 2024 Apr; 262(4):253-261. PubMed ID: 37940564
[TBL] [Abstract][Full Text] [Related]
4. Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram.
Maurichi A; Miceli R; Eriksson H; Newton-Bishop J; Nsengimana J; Chan M; Hayes AJ; Heelan K; Adams D; Patuzzo R; Barretta F; Gallino G; Harwood C; Bergamaschi D; Bennett D; Lasithiotakis K; Ghiorzo P; Dalmasso B; Manganoni A; Consoli F; Mattavelli I; Barbieri C; Leva A; Cortinovis U; Espeli V; Mangas C; Quaglino P; Ribero S; Broganelli P; Pellacani G; Longo C; Del Forno C; Borgognoni L; Sestini S; Pimpinelli N; Fortunato S; Chiarugi A; Nardini P; Morittu E; Florita A; Cossa M; Valeri B; Milione M; Pruneri G; Zoras O; Anichini A; Mortarini R; Santinami M
J Clin Oncol; 2020 May; 38(14):1591-1601. PubMed ID: 32167862
[TBL] [Abstract][Full Text] [Related]
5. Influence of regression, its extent and tumor-infiltrating lymphocytes on sentinel node status, relapse, and survival in a 10-year retrospective study of melanoma patients.
Maione V; Perantoni M; Bettolini L; Bighetti S; Arisi M; Tomasi C; Incardona P; Calzavara-Pinton P
Melanoma Res; 2024 May; ():. PubMed ID: 38564432
[TBL] [Abstract][Full Text] [Related]
6. Association between dermatology follow-up and melanoma survival: A population-based cohort study.
Huang Y; Fleming P; Fung K; Chan AW
J Am Acad Dermatol; 2024 Jun; 90(6):1161-1169. PubMed ID: 38368952
[TBL] [Abstract][Full Text] [Related]
7. A Review of Contemporary Guidelines and Evidence for Wide Local Excision in Primary Cutaneous Melanoma Management.
Orme SE; Moncrieff MD
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473257
[TBL] [Abstract][Full Text] [Related]
8. Melanoma in pregnancy: certainties unborn.
Zelin E; Conforti C; Giuffrida R; Deinlein T; di Meo N; Zalaudek I
Melanoma Manag; 2020 Jul; 7(3):MMT48. PubMed ID: 32922730
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy as a driver for melanoma.
Richtig G; Byrom L; Kupsa R; Schaider H; Hofmann-Wellenhof R; Wolf IH; Soyer HP; Richtig E
Br J Dermatol; 2017 Sep; 177(3):854-857. PubMed ID: 27718538
[TBL] [Abstract][Full Text] [Related]
10. Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.
Rubinstein JC; Han G; Jackson L; Bulloch K; Ariyan S; Narayan D; Rothberg BG; Han D
Cancer Med; 2016 Oct; 5(10):2832-2840. PubMed ID: 27671840
[TBL] [Abstract][Full Text] [Related]
11. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
[TBL] [Abstract][Full Text] [Related]
12. Wait Times for Melanoma Surgery: Is There an Association with Overall Survival?
Crawford AB; Nessim C; Weaver J; van Walraven C
Ann Surg Oncol; 2018 Jan; 25(1):265-270. PubMed ID: 29101504
[TBL] [Abstract][Full Text] [Related]
13. Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma.
Nelson DW; Stern S; Elashoff DE; Elashoff R; Thompson JF; Mozzillo N; Nieweg OE; Hoekstra HJ; Cochran AJ; Faries MB
J Am Coll Surg; 2017 Aug; 225(2):302-311. PubMed ID: 28668274
[TBL] [Abstract][Full Text] [Related]
14. Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse.
Mulder EEAP; Johansson I; Grünhagen DJ; Tempel D; Rentroia-Pacheco B; Dwarkasing JT; Verver D; Mooyaart AL; van der Veldt AAM; Wakkee M; Nijsten TEC; Verhoef C; Mattsson J; Ny L; Hollestein LM; Olofsson Bagge R
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740520
[TBL] [Abstract][Full Text] [Related]
15. Subtyping Cutaneous Melanoma Matters.
El Sharouni MA; van Diest PJ; Witkamp AJ; Sigurdsson V; van Gils CH
JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa097. PubMed ID: 33409460
[TBL] [Abstract][Full Text] [Related]
16. Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma.
Mulder EEAP; Dwarkasing JT; Tempel D; van der Spek A; Bosman L; Verver D; Mooyaart AL; van der Veldt AAM; Verhoef C; Nijsten TEC; Grunhagen DJ; Hollestein LM
Br J Dermatol; 2021 May; 184(5):944-951. PubMed ID: 32844403
[TBL] [Abstract][Full Text] [Related]
17. Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI).
Mandalà M; Galli F; Patuzzo R; Maurichi A; Mocellin S; Rossi CR; Rulli E; Montesco M; Quaglino P; Caliendo V; De Giorgi V; Merelli B; Caracò C; Piazzalunga D; Labianca A; Ribero S; Senetta R; Gianatti A; Valeri B; Massi D; Ascierto PA; Santinami M;
Eur J Cancer; 2020 Sep; 137():30-39. PubMed ID: 32739767
[TBL] [Abstract][Full Text] [Related]
18. COVID infection and sentinel lymph node procedure for melanoma: Management in a dermato-oncology center in a high-risk pandemic area.
Caliendo V; Picciotto F; Quaglino P; Ribero S
Dermatol Ther; 2020 Jul; 33(4):e13536. PubMed ID: 32385893
[No Abstract] [Full Text] [Related]
19. Desmoplastic melanoma: The role of pure and mixed subtype in sentinel lymph node biopsy and survival.
Laeijendecker AE; El Sharouni MA; Sigurdsson V; van Diest PJ
Cancer Med; 2020 Jan; 9(2):671-677. PubMed ID: 31804771
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
